Susan L. Solomon Center for Precision Medicine

In August 2022, the NYSCF Board of Directors committed to naming The NYSCF Research Institute laboratories after our extraordinary Founder & CEO, in tribute to her visionary and courageous leadership.

Susan was deeply honored by this decision, and gratified to know that her legacy would be supported and carried on by the community of stem cell champions she brought together in her lifetime.

The naming campaign for the Susan L. Solomon Center for Precision Medicine will support a critical expansion of NYSCF’s existing labs and clinical research programs that began under Susan, and which will deliver on the promise of precision medicine for the world’s patients.

Several of NYSCF’s clinical programs are on the verge of reaching patients, including a cellular therapy to treat agerelated blindness, a clinical test that identifies – in advance – the best drugs that will be most effective for ovarian cancer patients, and a proprietary drug discovery platform that combines artificial intelligence and robotics to advance precision medicine across multiple diseases, at a scale that can reflect the diversity of our human population.

Our laboratory expansion in contiguous space on the 2nd floor of our building will provide much-needed traditional tissue culture lab space and workstations for our scientists, as well as a new home for our groundbreaking cancer drug screening lab, our revolutionary precision medicine drug discovery center, and additional clinical-grade lab spaces, where we will conduct the essential work that will directly benefit patients.